XNAS
NAKA
Market cap22mUSD
Jul 09, Last price
3.81USD
1D
1.60%
1Q
-56.47%
IPO
-96.42%
Name
Kindly MD Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kindly MD, Inc. functions as a company specializing in both healthcare provision and health data management. It delivers direct patient care by integrating prescription medication management with behavioral health services. The firm offers specialized outpatient clinical services, accessible through both subscription-based plans and a fee-for-service structure, designed to complement conventional medical provisions. Its comprehensive service portfolio includes evaluation and management for various conditions such as chronic pain, functional medicine requirements, cognitive behavioral therapy (CBT), trauma and addiction recovery support, overdose prevention education, and peer-assisted programs. The company also provides limited urgent care, preventative medicine, travel-related health consultations, and hormone therapy. Beyond clinical services, Kindly MD, Inc. engages in data collection and research, executes online and email marketing campaigns, and retails healthcare products both within its clinics and through digital channels. Established in 2019 and headquartered in Salt Lake City, Utah, the company was formerly known as Utah Therapeutic Health Center, LLC before rebranding to Kindly MD, Inc. in March 2022.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | |
| Income | |||||
Revenues | |||||
Cost of revenue | |||||
Unusual Expense (Income) | |||||
NOPBT | |||||
NOPBT Margin | |||||
Operating Taxes | |||||
Tax Rate | |||||
NOPAT | |||||
Net income | |||||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | |||||
| Cash flow | |||||
Cash from operating activities | |||||
CAPEX | |||||
Cash from investing activities | |||||
Cash from financing activities | |||||
FCF | |||||
| Balance | |||||
Cash | |||||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | |||||
Invested Capital | |||||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | |||||
Price | |||||
Market cap | |||||
EV | |||||
EBITDA | |||||
EV/EBITDA | |||||
Interest | |||||
Interest/NOPBT | |||||